Indoleamine 2,3-dioxygenase (IDO) is the first enzyme in the kynurenine pathway. The kynurenines formed in this pathway chemically modify proteins and cause apoptosis in cells. Evidence suggests that kynurenines and their protein modifications are involved in cataract formation, but this has yet to be directly demonstrated. We generated transgenic (Tg) mouse lines that overexpress human IDO in the lens. Homozygous Tg (homTg) lenses had higher IDO immunoreactivity, B4.5 times greater IDO mRNA, and B8 times higher IDO activity compared to lenses from hemizygous Tg (hemTg) animals. The kynurenine content was threefold higher in homTg than in hemTg but was not detected in wild-type (Wt) lenses. Kynurenine modifications were B2.6 times greater in homTg than in hemTg or Wt. HomTg lenses had vacuoles in the epithelium and cortical fiber cells. Kynurenine modifications coincided with apoptosis in the secondary fiber cells of homTg lenses. Caspase-3 and caspase-9 activities were markedly higher in homTg than in hemTg and Wt. The glutathione content was B36% lower in homTg compared to hemTg and Wt lenses. HomTg animals also developed bilateral cataracts within 3 months of birth. Together these data demonstrate that IDO-mediated production of kynurenines results in defects in fiber cell differentiation and their apoptosis and suggest that IDO activity is kept low in the lens to prevent deleterious effects by kynurenines.
The kynurenine (KYN) pathway is the primary route of L-tryptophan catabolism and a source of NAD. 1 In extrahepatic tissues, the KYN pathway is initiated by indoleamine 2,3dioxygenase (IDO). IDO is a heme-containing dioxygenase; it oxidizes L-tryptophan to N-formylkynurenine (NFK). Further catalysis of NFK leads to the formation of NAD. 2 IDO synthesis is induced by inflammatory stimuli, especially interferon-g. Enhanced synthesis of IDO appears to deplete tryptophan and restrict viral and bacterial growth and infection. 3 IDO has been implicated in the protection of fetal allografts from maternal T-cell-mediated immunity, possibly through KYN-mediated apoptosis of thymocytes. 4, 5 Inhibition of T-cell-mediated immunity by IDO is also involved in engraftment of skin substitutes 6 and transplantation of other organs. 7 IDO secreted by tumor cells starves T cells by depleting tryptophan, 8 and inhibition of IDO promotes tumor regression. 9 Thus, IDO appears to have important functions in infection, inflammation, and T-cell-mediated immunity.
Although these effects are defensive strategies to cope with infection and inflammation, they may have unintended consequences because KYNs formed during IDO-mediated degradation of tryptophan can chemically modify proteins and have been shown to be cytotoxic. 10, 11 In coronary heart disease, inflammation and immune activation are associated with increased blood levels of KYN, 12 possibly through interferon-g-mediated activation of IDO. In experimental chronic renal failure, activation of IDO leads to increased blood levels of KYNs, 13 and in uremic patients KYN-modified proteins are present in urine. 14 Further, renal IDO expression may be deleterious during inflammation because it enhances tubular cell injury. 15 KYNs and IDO also are implicated in the pathophysiology of neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's diseases, and KYNs have been shown to be neurotoxic. 10, [16] [17] [18] [19] Tryptophan degradation increases in rheumatoid arthritis 20 and development of collagen-induced arthritis in mice is associated with increased IDO activity and enhanced tryptophan catabolism. 21 These observations suggest that KYN may contribute to various neurological, renal, and inflammatory pathologies. Chronic inflammation in these diseases may be an underlying factor for IDO overexpression.
Several recent studies, especially those investigating the eye lens, shed light on how KYNs might chemically alter protein structure. In the human lens, IDO activity is present mainly in the anterior epithelium. 22 Several KYNs, such as KYN, 3-hydroxykynurenine, and 3-hydroxykynurenine glucoside, are present in the lens. 23 They are thought to protect the retina by absorbing UV light and therefore are commonly referred to as UV filters. However, several recent studies show that KYNs are prone to deamination and oxidation. 24 The deamination results in formation of a,b-unsaturated ketones that chemically react and modify lens proteins. Such reactions occur mostly at cysteinyl, histidinyl, and lysyl residues. 25 The predominant modifications appear to be Michael adducts; however, other more stable and proteincross-linking adducts also are likely, but their structures are not fully understood.
In the normal human lens, KYN modifications increase after 50 years of age, 26 and in cataractous lenses they decrease due to degradation. 27 Our studies, using highly specific monoclonal antibodies (mAbs), have provided additional support for the presence of Michael adducts in proteins of the human lens. 28, 29 These observations suggest that KYNmediated modification could contribute to the lens protein modifications during aging and cataractogenesis. They may also reduce the chaperone function of a-crystallin, which is necessary for maintaining lens transparency. 30 Although these observations link KYN formation to aging and cataract formation, whether KYN formation is directly involved in lens protein modification and cataract development has yet to be demonstrated. To address this issue, we have generated transgenic mouse lines that express high levels of IDO in the lens. Using this model, we show that IDO overexpression adversely affects lens development, causes massive apoptosis of fiber cells, and leads to poorly differentiated fiber cells and cataract formation.
MATERIALS AND METHODS Establishment of Transgenic Mouse Lines Expressing hIDO
The studies conformed to the ARVO Statement on the Use of Animals in Ophthalmic and Vision Research and were approved by the Case Western Reserve University Institutional Animal Care and Use Committee. Two independent transgenic mouse lines were produced by the standard pronuclear microinjection technique. The details of the transgene DNA construct are illustrated in Figure 1 . The human IDO (hIDO) gene was inserted between EcoR1 sites of a minigene construct, which contained a chick d1-crystallin lens enhancer upstream of the aA-crystallin promoter and a rabbit b-globin intron. Human growth hormone polyA was inserted downstream from the aA-crystallin promoter. At 2-3 weeks after birth, tail biopsies were obtained, and genomic DNA was screened for the transgene integration using PCR with forward primer 5 0 -TCTGAGAGCCTCTGCTGCTC-3 0 and reverse primer 5 0 -GGTCCATGGTGATACAAGGGAC-3 0 . Identified founders were crossed with wild-type (Wt) C57BL/ 6 to establish a hemizygous transgenic (hemTg) line. Homozygous transgenic (homTg) mouse lines were established by breeding the hemizygous mice within the same line.
Morphological Changes
Mice were killed by CO 2 asphyxiation. Following dissection, lenses were immediately placed on an electron microscopy grid to assess opacity. Lenses were then examined in bright field using a Â 4 objective on an Olympus BX-60 upright microscope (Olympus, Tokyo, Japan). Images were captured in color using a SPOT RT Slider camera (Diagnostic Instruments, Sterling Heights, MI, USA). Lens diameter measurements were carried out using Spot software version 3.5.5.
Hematoxylin and Eosin Staining
Immediately after dissection, eyes were fixed in 10% neutralbuffered formalin, embedded in paraffin, cut into 5-mm sections, and stained with hematoxylin and eosin using a standard procedure.
Electron Microscopy
Mouse eyeballs were fixed with triple aldehyde-DMSO fixative for 2 h at room temperature. The specimens were thoroughly rinsed in 0.1 M phosphate buffer (pH 7.4), and then fixed for 2 h in a buffered 1:1 mixture of 2% osmium tetroxide and 3% potassium ferricyanide. After rinsing in water, the specimens were soaked overnight in an acidified solution of 0.25% uranyl acetate. After another rinse in distilled water, they were dehydrated in ascending concentrations of ethanol, passed through propylene oxide, and embedded in an Epon mixture. Sections (80 nm) were cut with an RMC MT 6000-XL ultramicrotome. The sections were sequentially stained Figure 1 Transgene. Schematic representation of the hIDO transgenic construct. The chick d1-crystallin enhancer (d1) was fused to the mouse aAcrystallin promoter (aA-P) to make the chimeric promoter, denaA. The hIDO cDNA was inserted between the b-globin intron (b-glo int) and human growth hormone polyA signal (hGH pA, 660 bp).
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Slit Lamp Imaging
Animals were anesthetized by 2,2,2-tribromoethanol in 2-methyl-2-butabol (both from Sigma-Aldrich) (i.p. injection at 0.2 ml per 10 g). Pupils were dilated with topically applied 0.5% mydriacyl and examined using a fixed slit lamp with an adapted Nikon D2Xs digital SLR camera. Images were taken using axial light with full illumination. Slit beams were offset by 101; minimum beam size was used and additional fill light was provided with a fiber optic source.
IDO Activity
Lenses were homogenized on ice in 200 ml PBS and centrifuged (14 000 g, 41C, 15 min). Supernatants containing water-soluble proteins were used for the IDO assay. The reaction mixture contained 50 mM sodium phosphate buffer (pH 6.5), 20 mM ascorbic acid sodium salt, 200 mg/ml bovine liver catalase (Sigma-Aldrich), 10 mM methylene blue, and 400 mM L-tryptophan. The reaction was carried out at 371C for 1 h and was stopped with 40 ml 30% (w/v) trichloroacetic acid (TCA). The samples were incubated at 651C for 15 min to convert NFK to KYN and then centrifuged (14 000 g, 41C, 15 min). Controls were prepared in the same way except that the water-soluble protein was incubated with an IDO inhibitor, 20 mM 1-methyl-D,L-tryptophan (Sigma-Aldrich). KYN content was estimated by reverse-phase HPLC along with standards ranging from 0.2 to 5.0 nM L-KYN (Sigma-Aldrich) using a GraceVydac C18 column (250 Â 4.6 mm, 5.0 mm) with ammonium acetate (10 mM) as solvent A and 10% methanol in ammonium acetate as solvent B. The percentage of solvent B in the gradient was 0% (10 min), 0-100% (10 min), and 100-0% (15 min). The flow rate was 0.8 ml/min. The eluant was monitored at 360 nm (Jasco UV-970 UV-VIS detector), and the peak areas were determined using PowerChrom software. IDO activity was expressed as nanomoles of KYN formed per milligram protein per minute. Protein concentration was determined using the Bio-Rad reagent. Quantification of hIDO mRNA RNA was extracted from lenses using TRIZOL reagent, and RNA quality was verified by agarose gel electrophoresis. cDNA was generated using the Super Script First Strand Synthesis System for RT-PCR (Invitrogen). Total RNA, 2.5 mg, was denatured, then reverse-transcribed using random primers in a reaction mixture containing RT buffer, 10 mM dNTP, RNase inhibitor, reverse transcriptase, and DTT at 421C for 1.5 h in a Bio-Rad iCycler. Amplification was verified by electrophoresis. The hIDO cDNA was first amplified with gene-specific primers: forward 5 0 -CACTTTGCTAAAGGCGCTGTTGGA-3 0 and reverse 5 0 -GGTTGCCTTTCCAGCCAGACAAAT-3 0 using the Invitrogen PCR Reagent System. The PCR product was 140 bp and the amplification specificity was verified by electrophoresis. The cDNA concentration was determined and standards ranging from 1 Â 10 9 to 1 Â 10 0 cDNA molecules were prepared. Real-time PCR was performed on duplicate samples and the standards using SYBR Green PCR Master Mix (Applied Biosystems). The PCR protocol comprised an initial denaturation step at 951C for 10 min followed by 40 cycles of denaturation (951C, 15 s each) and annealing/extension (601C, 1 min). In preliminary experiments, the PCR products were visualized by agarose gel electrophoresis to verify that a single product was amplified. Real-time PCR data were analyzed with an ABI PRISM 7700 detector using ABI PRISM 7700 dissociation curve software (Applied Biosystems).
Immunostaining of IDO

Kynurenine Content
Lenses were weighed and homogenized in 100 ml ethanol. The homogenate was stored at À201C for 1 h and then centrifuged (14 000 g, 101C, 15 min). The supernatant was removed, kept at À201C whereas the pellet was reextracted with 100 ml, 80% ethanol. The homogenate was kept at À201C for 1 h, centrifuged as before, and the supernatants were combined and dried in a SpeedVac concentrator. Samples and standards (0.2-5.0 nmol of KYN) were analyzed by reversephase HPLC as described above. Sodium acetate (20 mM)/ acetic acid buffer (pH 4.5) used as solvent A and 20% methanol as solvent B. The percentage of solvent B in the gradient was 0% (30 min), 0-50% (2 min), 50-100% (8 min), Kynurenine-mediated protein damage in lens M Mailankot et al and 100-0% (6 min). The flow rate was 0.6 ml/min. KYN was expressed as nmol/mg lens.
ELISA for Kynurenine-Mediated Lens Protein Modification
Microplate wells were coated with water-soluble lens proteins in 0.05 M carbonate buffer (pH 9.7) at a concentration of 1 mg per 50 ml, incubated for 1 h at 41C, and then washed three times with PBST. The wells then were blocked with 5% nonfat dry milk in PBST and washed three times with PBST. The primary antibody, mouse anti-KYN mAb 29 (1:1000 diluted in PBS), was added, the plates were incubated for 1 h at 371C, washed with PBST, and then incubated with HRPconjugated goat anti-mouse IgG secondary antibody (Promega; 1:15 000 in PBST). Substrate was added (3,3 0 ,5,5 0tetramethylbenzidine (Sigma-Aldrich) with H 2 O 2 ), the reaction stopped, and absorbance was measured at 450 nm. Primary and secondary antibody specificity was verified by preincubating the primary antibody with KYN-modified RNase A and incubating coated wells with secondary antibody only.
Immunostaining for Kynurenine Modification
After rehydration, high-temperature antigen retrieval, and incubation in 3.0% H 2 O 2 , paraffin-embedded sections were blocked with goat serum. The sections were rinsed briefly in PBS and incubated with anti-KYN mAb (1:500 diluted in PBS) or anti-KYN mAb incubated with KYN-modified RNase A. Sections were then incubated with goat anti-mouse IgG Texas Red (1:400 diluted in PBS; Molecular Probes), rinsed, incubated with DAPI/Vectashield, and then permanently mounted. The negative control was processed similarly but without the primary antibody. Images of lenses were acquired on a Leica DMI 6000 B inverted microscope using a Â 20 objective and a Retiga EXI camera (QImaging, Vancouver, BC, USA). To obtain 'stitched' images, Metamorph software (Molecular Devices Corp., Downingtown, PA, USA) was used.
Incubation of Lens Homogenate with L-Tryptophan
Water-soluble lens protein was incubated with or without 1 mM L-tryptophan for 12 h at 371C, after which the samples were mixed with an equal volume of 20% TCA and centrifuged at 14 000 g, 101C, 15 min. The supernatant was assayed for KYN by reverse-phase HPLC as described above. KYN concentrations were expressed as pmol/mg protein.
Organ Culture with L-Tryptophan Each lens was carefully dissected by a posterior approach and placed in the well of a 12-well culture plate containing 2 ml M199 medium (pH 7.4, 300 ± 5 mOsm; Sigma-Aldrich) and incubated for 6 h in a CO 2 incubator. Only transparent lenses were selected for further assay. M199 medium containing 1 mM L-tryptophan (stock made in 2 N NaOH) was prepared (pH 7.4 and 300±5 mOsm). The medium was changed every 24 h for 3 days, after which KYN was assayed by reverse-phase HPLC as described above and was expressed as nmol/mg lens.
Measurement of Glutathione
Glutathione (GSH) was determined according to the method of Cui and Lou. 31 Lens homogenate was prepared as described above for the incubation with L-tryptophan, and 10 ml was mixed with 10 ml 5,5 0 -dithiobis(2-nitrobenzoic acid) (2.0 mg per 2.5 ml methanol). The volume was adjusted to 200 ml with 1.0 M Tris-HCl buffer (pH 8.2), containing 0.02 M EDTA. Absorbance of the reaction product was measured at 412 nm.
Apoptosis
After rehydration and antigen retrieval by microwave irradiation in 0.1 M citrate buffer (pH 6.0), paraffin-embedded sections were stained for apoptosis in situ using a kit (In situ Cell Death Detection Kit; Roche) as per the manufacturer's instructions. The sections were counterstained with DAPI. For the negative control, sections were incubated without terminal transferase.
Measurement of Caspase-3 and Caspase-9 Activity
Freshly dissected whole lenses were homogenized in 50 mM Tris-buffered saline. An equal volume of fluorogenic substrate solution (2 Â reaction buffer: 10 mM DTT, and 50 mM Ac-DEVD-AFC (for caspase-3) or Ac-LEHD-AFC (for caspase-9)) was added to each lysate. Lysates were incubated for 2 h at 371C in the dark. Samples were read in a spectrofluorometer (FluoroMax-4; HORIBA Jobin Yvon, USA) at excitation/emission wavelengths of 400/505 nm. Recombinant human caspases (Calbiochem) were used as positive controls.
Identification of KYN-Modified Proteins
Lens homogenate from Wt or homTg lenses corresponding to 200 mg protein in PBS was incubated with 2 mg mouse anti-KYN mAb or nonimmune IgG for 1 h at room temperature followed by addition of protein G-sepharose. The mixture was again incubated on a shaker for 1 h at room temperature. After centrifugation the pellet was washed five times with PBS. To do SDS-PAGE, the pellet was boiled with SDS sample buffer for 5 min at 951C, centrifuged and the supernatant was run on 15% Tris-HCl buffer. The gel were stained with Bio-Safe staining solution (Bio-Rad) and destained in water. A major protein band (indicated by an arrow in Figure  10c ) was cut out from the gel, minced, and subjected to in-gel digestion with trypsin and the peptides were analyzed on an LTQ linear ion trap mass spectrometer (Thermo Fisher Scientific) coupled with an Ettan MDLC system (GE Healthcare). The spectra were acquired by data-dependent methods: one full scan (m/z of 300-2000) followed by MS/MS on the five most abundant precursor ions at the 30% normalized collision energy. The dynamic exclusion was set as follows:
repeat count, 1; repeat duration, 45 s; and exclusion duration 180 s. The obtained data were submitted to Mascot by searching Swiss-Prot (sprot 50.3) mouse database, which includes 228670 sequences, 83849098 residues.
Statistics
The results were analyzed using one-way analysis of variance, followed by the Fisher's protected least significant difference test (using Statview 5.0 software, SAS Institute Inc.). The level of significance was set at less than 0.05.
RESULTS
Transgenic Mouse Lines
One hemizygous-independent and two homozygous-independent lines were established. HomTg lines were characterized by smaller eyes (Figure 2a ). All transgenic lines showed normal reproductive patterns and longevity. Both nontransgenic and transgenic animals received the same diet and developed normally. In addition, to control for possible effects of the promoter on morphological and developmental features in the hIDO overexpression animals, we examined eyes and lenses from C57BL/6 mice that overexpress glyoxalase-I. In this mouse, the chicken d1-crystallin enhancer and aA-crystallin promoter construct were used to drive overexpression of glyoxalase-I in the lens (Gangadhariah et al., unpublished observation) but lens development and morphology were normal. We used B3-month-old mice for the entire study, as at this age homTg animals had bilateral mature cataracts (see below).
Morphological Changes
Lenses from the homTg lines failed to attain normal weight and diameter. Compared to Wt, in homTg lenses the weight was reduced by 91% and the diameter was reduced by 64% (Figure 2b and 2c ). HomTg lens shape and histology also differed ( Figure 3) . The anterior and posterior segments lacked typical opposite-end curvature and clearly failed to overlap and form normal suture branches between and within successive growth shells (Figure 3a) . The lens epithelium in homTg lenses had vacuoles (Figure 3b ). The equatorial segments were also vacuolated in these lenses ( Figure  3c ). In homTg, a large number of nucleated cells were present throughout lens, indicating defects in denucleation of fiber cells (Figure 3d ). In contrast, lenses from hemTg, Wt, and glyoxalase-I-overexpression mice contained no vacuoles or nucleated fiber cells.
To investigate ultrastructural morphological differences in epithelial and fiber cells, we prepared homTg and Wt lenses for thin-section electron microscopy. In the Wt, the fiber cell architecture was regular (Figure 4a ). Characteristic gap junctions were frequent between fiber cells. In contrast, in homTg lenses, the fiber cells were disorganized and swollen with many large vacuolar structures (Figure 4b ). Gap junctions were scarce. The epithelial cells in Wt lenses formed a monolayer, and both epithelial and fiber cells showed tight connections in lenses (Figure 4c ). In contrast in homTg lenses, the epithelial cells irregularly arranged, interdigitated with each other, and were loosely opposed to the fiber cells (Figure 4d ).
Lenses from homTg lines had a strikingly dense nuclear cataract ( Figure 5a ) and opacity (Figure 5b) ; the cataract developed in both homozygous lines after about 3 months of age. The hemTg lens had no evidence of cataract formation and was similar to the Wt and glyoxalase-I-overexpression mouse lenses at this age. 
IDO Overexpression
IDO activity in the lens was quantified by estimating the amount of KYN formed upon incubation of water-soluble lens proteins with 1 mM L-tryptophan. Reverse-phase HPLC revealed a peak at 12-14 min that corresponded to KYN (Figure 6a ). Both homTg and hemTg lenses showed IDO activity whereas the Wt showed negligible activity (Figure 6b ). Enzyme activity increased approximately eightfold in homTg compared to hemTg lenses. Heat treat-ment (651C, 15 min) abolished enzyme activity, and incubation with the IDO inhibitor, 1-methyl tryptophan resulted in a 40% reduction in the enzyme activity in homTg lens proteins confirming that the measured activity was from IDO.
IDO localization in the lens was determined by immunohistochemistry (Figure 6c ). In homTg lens, prominent DAB staining was observed throughout the lens. In hemTg lens, staining occurred only in the anterior epithelium and to The negative control where the primary antibody was omitted did not show immunoreaction. The Wt lens did not show appreciable DAB staining. Western blotting using an mAb for hIDO showed a protein band corresponding to the molecular weight of IDO (45 kDa). The hIDO mRNA level was assessed with real-time PCR. The mRNA level was 4.5-fold higher in homTg than in hemTg lenses. Wt lenses showed no hIDO mRNA (Figure 6d ). These data suggest that both the IDO transcript and protein are elevated in homTg and hemTg lenses and resulted in higher enzyme activity.
Kynurenine Content and Protein Modification
Lenses from transgenic animals showed KYN, whereas it was not detected in Wt lenses (Figure 7a ). KYN levels were approximately threefold higher in lenses from homTg compared to those from hemTg. To determine if KYN formation occurred in younger than 3-month-old lenses, we determined KYN content in 1-month-old Wt and homTg lenses. At this age, homTg lenses were transparent, but much smaller than Wt lenses of same age. The KYN levels at this age were already elevated (Supplementary Figure S1a) . KYN-modified proteins were measured by a direct ELISA. The mAb used in this assay was developed by us and Kynurenine-mediated protein damage in lens M Mailankot et al it recognizes mainly the Michael adduct formed from the reaction of histidine with deaminated KYN. 25 The homTg lenses exhibited B2.7 times greater KYN modifications compared to hemTg lenses. The lenses from Wt showed little modifications (Figure 7b ). No immunoreactivity was present when the primary antibody was preincubated with KYN-modified RNase A (data not shown). These data suggest that overexpression of hIDO resulted in greater KYN and KYN-modified proteins in the transgenic animal lenses.
To localize lens protein modifications produced by KYN, we performed immunohistochemistry on paraffin-embedded sections. Immunoreactivity was present throughout the homTg lens, but predominated in the central nuclear region (Figure 7c ). The hemTg (C2) lenses showed much weaker immunoreactivity compared to the homTg (C3). Interestingly, immunoreactivity in homTg lenses coincided with the nucleated fiber cells. The immunoreactivity was markedly reduced when the antibody was preincubated with KYNmodified RNase A (C6). Together these results demonstrate that in transgenic lenses, enhanced IDO activity leads to higher KYN content and KYN-modified proteins. These results also suggest that KYN modifications may be responsible for nucleated undifferentiated fiber cells.
To determine if KYN modification preceded cataract development, we determined KYN modification by immunohistochemistry in 1-month-old homTg and Wt lenses. Unlike 3-month-old lenses (Figure 7, C3) , 1-month-old lenses showed KYN modified proteins in the outer cortical region, more densely at the bow regions (Supplementary Figure S1b) . These observations together with results in Supplementary Figure S1a suggest that KYN formation and KYN modification of proteins occur before development of mature cataracts in homTg animals.
Incubation of Lens Homogenate and Lens Organ Culture with L-Tryptophan
Incubation of water-soluble lens proteins from transgenic mice with L-tryptophan resulted in KYN formation (Figure 8a) . KYN formation increased approximately sevenfold in proteins from homTg lens compared with hemTg lenses. The Wt lens proteins did not produce KYN. These experiments also revealed that B12% of added L-tryptophan was converted to KYN within 1 h in homTg lens protein extract, whereas only B1.5% was converted in hemTg lens proteins.
To determine whether KYN formation occurs in intact lenses, we performed organ culture experiments, in which we incubated whole lenses with 1 mM L-tryptophan. Similar to results for isolated proteins, KYN increased by 5-fold in homTg lenses and 3.2-fold in hemTg lenses (Figure 8b ). The formation of KYN from lens proteins and whole lenses of transgenic animals also suggests that IDO overexpression causes higher production of KYN in the lens.
Glutathione Level GSH levels were reduced by 36% in homTg lenses in comparison to Wt and hemTg lenses (Figure 8c ). In 1-month-old homTg lenses, GSH levels were reduced by B13% in comparison to 1-month-old Wt lenses (Supplementary Figure  S2 ). This suggests that the loss of GSH started to occur (along with KYN formation) before the onset of mature cataracts in homTg animals.
Apoptosis TUNEL staining revealed apoptosis in the homTg lens nucleus (Figure 9a ). Staining of the same sections for KYN modifications revealed that many cells that were TUNEL positive were also positive for KYN modifications (Figure 9b), and that KYN modifications appeared to be present in both the cytoplasm and the nucleus. These findings suggest IDO overexpression causes apoptosis of fiber cells and could be due to KYN modifications of cytosolic and nuclear proteins and DNA. Apoptosis of fiber cells were seen, albeit to a lesser extent, in 1-month-old homTg lenses (Supplementary Figure S3 ). This, together with data in Supplementary Figures  S1a and b , suggests that apoptosis, probably as a consequence of KYN formation, started to occur in precataractous lenses.
To further establish apoptosis in transgenic lenses, we measured caspase-3 and caspase-9 in lens homogenate. Caspase-3 activity was fivefold higher in homTg lenses when compared to hemTg and Wt lenses (Figure 10a ). Likewise, caspase-9 activity was fivefold higher in homTg animals compared to lenses from hemTg and Wt lenses (Figure 10b) . These results suggest that IDO overexpression activates apoptosis in lens fiber cells.
Identification of KYN-Modified Proteins
Proteins from homTg lenses were immunoprecipitated using the KYN mAb. The immunoprecipitated proteins were separated on SDS-PAGE. Several protein bands were observed (Figure 11 ). The major protein band was subjected to mass spectrometry analysis. Several proteins, mostly b-crystallin subtypes, were identified, in addition to aAand aB-crystallins (Table 1 ). Our initial attempts to identify specific sites of KYN modification on b-crystallins were not successful, possibly because of structural diversity of modifications and/ Prominent DAB staining (dark brown) was observed throughout the homTg lens. In hemTg lens, staining occurred only in the anterior epithelium and to some extent in the bow and outer posterior regions. Wt lens did not show appreciable DAB staining (magnification Â 4). The negative control (labeledcontrol), where the primary was omitted did not show DAB staining. The inset shows western blotting for IDO (45 kDa) in the water-soluble proteins using the IDO monoclonal antibody (1:5000 diluted). Lane 1, Wt; lane 2, hemTg; lane 3, homTg. GAPDH loading control (36 kDa) is also shown. (d) Quantitative real-time PCR analysis for hIDO mRNA showed that hIDO mRNA was 4.5-fold higher in homTg lens than in hemTg lens. In the Wt lens no hIDO mRNA was present. Results shown are mean ± s.d. of five lenses from five mice. *Po0.0001.
Kynurenine-mediated protein damage in lens M Mailankot et al or low abundance of modification relative to protein concentration, but we hope to identify such sites with more sophisticated approaches in the future. Our attempts to identify proteins by western blotting also failed. The KYN antibody did not react with proteins in western blotting (these proteins had relatively large quantities of KYN modification as judged by ELISA, see Figure 7b ). We believe that the antigenic epitope gets masked or destroyed during SDS-PAGE and/or western blotting (possibly by the reduction of the ketone group on the Michael adduct). Further studies are needed to verify this possibility.
DISCUSSION
The purpose of this study was to investigate the function of KYNs in lens protein modifications. We found that overexpression of IDO in the lens results in enhanced KYN formation. Thus, enough L-tryptophan must have been available to support the increased KYN formation. This is further supported by the finding that in organ-cultured homTg lenses, adding L-tryptophan enhanced KYN formation. We did not determine the amount of NFK formed, but because we detected higher levels of KYN in homTg animals as compared to hemTg or Wt animals, it suggests that kynurenine formamidase was not rate limiting. However, it is also possible that NFK was nonenzymatically converted to KYN. Second, the KYN produced from IDO reacted with proteins to form adducts that were detected by an mAb directed against KYN modification. We also found that KYN modification occurred in the cytosol and nuclei of fiber cells, and cells containing KYN modifications underwent apoptosis. Finally, IDO overexpression caused severe morphological changes in the lens. All our studies were carried out with 3-month-old lenses, the homTg lenses had dense cataracts at this time. The question arose as to whether cataract formation was related to KYN formation. Our data on lenses from 1-month-old homTg mice showed that the KYN content and KYN modification of proteins along with fiber cell apoptosis and GSH loss were already increased at this age. This suggests that further increase in these changes could have resulted in cataract formation in 3-month-old lenses ( Figure 5 ). KYNs must be deaminated to produce adducts in proteins. GSH is believed to inhibit such adduction by binding to KYN. Mammalian lenses, including those in human, have high levels of GSH. 32 However, in aging and cataractous lenses, GSH levels are reduced, 33, 34 which could lead to increased KYN modification of proteins. Our data showing that GSH levels are significantly reduced in homTg lenses further support this view. It is also possible that reactive oxygen species produced from KYNs 35 could have oxidized GSH and promoted reaction between KYN and proteins. It is noteworthy that in ground-squirrel lenses, even though KYN levels are relatively high, the lenses are clear, possibly because the GSH level is also extremely high. 36 It is possible that the severe morphological changes observed with IDO overexpression were due to overexpression of the protein alone rather than its associated increased activity. However, our finding that the glyoxalase-I-overexpression mice, which have the same transgene construct but normal morphology, rules out such an effect. Therefore, it is likely that enhanced IDO expression and activity led to the morphological defects seen in the IDO transgenic lenses.
The morphological changes were highlighted by improper terminal differentiation of fiber cells (ie, nucleated). During normal lens development, epithelial cells stop dividing at the lens equatorial region and differentiate into elongated fiber cells, during which time they lose their nuclei and other organelles. 37 The poor differentiation we observed suggests a serious abnormality in organelle degradation. Although the precise mechanisms for organelle degradation are not known, 
Figure 11
Identification of KYN-modified proteins. Water-soluble lens proteins were incubated with KYN antibody, Protein A/G sepharose gel was pelleted and subjected to SDS-PAGE followed by western blotting using KYN antibody. The major protein band (thick arrow) was analyzed by mass spectrometry and the results are presented in it is believed that a gradient formed by diffusible substances, in particular intracellular oxygen, is one cause. 38 It is possible that in the homTg lenses, such a gradient was altered and resulted in the loss of cues necessary for organelle degradation.
The absence of differentiation may also be due to an effect of KYNs on cell signaling, transcription, and growth factors. Fibroblast growth factor, IGF-1, and bone morphogenetic protein have been implicated in stimulation of fiber cell differentiation. [39] [40] [41] [42] In addition, it has been demonstrated that the PI3K pathway regulates initiation of lens cell differentiation by signaling a reorganization of the actin cytoskeleton from stress fibers to cortical fibers. 43 Furthermore, targeted mutations in the genes encoding c-Maf, Sox1, and Prox1 have all resulted in specific defects in fiber cell differentiation, [44] [45] [46] implicating these transcription factors in epithelial cell differentiation. KYNs may have affected any one of these factors, thereby affecting fiber cell differentiation. Such effects of KYN may be due to chemical modifications of proteins or through formation of reactive oxygen species. The mass spectrometric analysis of proteins from homTg lenses suggested that major proteins of the lens (a-and b-crystallins) are modified by KYN. For that analysis, we selected only the major band from the SDS-PAGE of the immunoprecipitated sample ( Figure 11 ). Other minor protein bands that were not analyzed might contain proteins that are involved in fiber cell differentiation. Further work is needed to verify this possibility.
Several previous studies have shown that extracellular KYNs can induce apoptosis, [47] [48] [49] but none has demonstrated that intracellular KYN formation can induce apoptosis. Our study strongly implicates intracellular KYNs, KYN modifications, or both in apoptosis. Although we did not determine whether nuclear protein or DNA modification was required, such an event is likely. The idea that KYNs induce fiber cell apoptosis is supported by a recent study showing that kidney tubular epithelial cells that overexpress IDO undergo apoptosis, 15 possibly through formation of KYNs. Another recent study showed that fiber cells undergo apoptosis in aA/aB-crystallin knockout mice, suggesting a function for a-crystallins in preventing fiber cell apoptosis. 50 Whether a-crystallin's potential ability to inhibit apoptosis was compromised in homTg animal lenses is uncertain, but KYN modification can cause the loss of chaperone function, 30, 51 which is likely related to a-crystallin's anti-apoptotic activity. It is probable that KYNs affected FGF-R signaling, as it is required for early and late fiber cell differentiation and survival of terminally differentiated fiber cells. 52 Only the homTg mice exhibited reduced eye size, which is common in transgenic mouse models that lack growth factors or proteins involved in cell-cycle regulation. 53, 54 Inactivation of Rho GTPase by selective expression of the C3exoenzyme 55 or expression of diphtheria toxin with regulatory sequences associated with g2-crystallin gene 56 also results in a smaller lens and microphthalmia in mice. It is possible that diphtheria toxin and KYNs exert similar cytotoxic effects that lead to lens developmental defects and smaller lenses.
In the lens, IDO is present primarily in epithelial cells. In the normal transparent lens, IDO activity may be kept to a minimum so that its activity is sufficient to produce the low quantity of KYN needed to filter out UV light. Such regulation of IDO activity might occur at posttranslational level. IDO activity has been reported to be inhibited by NO and H 2 O 2.
57,58 Both modifications are reversible and therefore could be involved in regulating IDO activity. During anterior segment infection, interferon-g increases in the aqueous humor. If IDO activity goes unchecked due to stimulation by interferon-g, then the enhanced IDO activity in the lens may impart considerable damage. In fact, elevated levels of aqueous humor interferon-g concentrations are associated with cataract formation, 59 and ectopic expression of interferon-g disrupts fiber cell differentiation and leads to cataract formation in mice. 60, 61 It will be of interest to determine whether IDO activity is elevated and consequently KYN production enhanced when interferon-g is elevated in the lens.
In summary, our study provides the first evidence that KYNs formed within the lens are cytotoxic and bring about changes that are similar to those that occur during cataract formation. This animal model may also be useful for understanding pathologies of other diseases, such as Alzheimer's and Parkinson's diseases, where KYNs appear to be involved.
Supplementary Information accompanies the paper on the Laboratory Investigation website (http://www.laboratoryinvestigation.org)
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